Sage Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 10, 2020--
Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Thursday, February 27, 2020 at 8:00 a.m. EST to report its fourth quarter and full year 2019 financial results and discuss recent business updates.
The webcast can be accessed on the investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200210005122/en/
CONTACT: Investor Contact
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH OTHER HEALTH
SOURCE: Sage Therapeutics
Copyright Business Wire 2020.
PUB: 02/10/2020 06:30 AM/DISC: 02/10/2020 06:30 AM